ClinVar Miner

Submissions for variant NM_000074.3(CD40LG):c.347-1G>A

dbSNP: rs2076118841
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001193392 SCV001362177 pathogenic Hyperimmunoglobulin M syndrome 2019-02-25 criteria provided, single submitter clinical testing Variant summary: CD40LG c.347-1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict the variant abolishes a canonical 3' acceptor site. These predictions have been confirmed by several studies that performed cDNA sequence analysis on patient derived mRNA, demonstrating an in-frame exon 4 (63 bp) skipping (Scholl 1998, Garcia-Perez 2003, Lee 2005). These studies also demonstrated the lack of the CD40L protein on the surface of activated lymphocytes (Scholl 1998, Garcia-Perez 2003). The variant was absent in 178376 control chromosomes (gnomAD). c.347-1G>A has been reported in the literature in affected individuals (Leven 2016, Lee 2005, Garcia-Perez 2003, Scholl 1998). These data indicate that the variant is likely to be associated with disease. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.